• Dihydrotestosterone Workflows for AR Research

  2026-08-14

  Dihydrotestosterone provides a controlled androgen receptor activation tool for connecting AR activity with EGFR, ERBB2, AKT, and ERK responses. This practical guide translates DHT handling, bladder cancer assays, and bone-microenvironment resistance findings into reproducible workflows with troubleshooting support.

• SGI-1027–Everolimus Cooperation in Renal Cancer

  2026-08-14

  The reference study identifies SGI-1027 as a methuosis inducer in renal cancer and shows that it cooperates with everolimus to suppress tumor-cell growth, migration, and invasion. Its mechanistic contribution is the connection between lysosomal membrane permeability, apoptosis, and GSDME-dependent pyroptosis, providing a framework for investigating everolimus-resistant renal cell carcinoma.

• Kanamycin Sulfate in Infection Research

  2026-08-13

  Kanamycin Sulfate gives microbiology workflows a practical, water-soluble antibiotic for resistant-strain selection, growth controls, and mechanistic studies. Used alongside toxin-focused assays, it helps separate bacterial viability effects from anti-virulence activity while exposing important antibiotic and microbiome confounders.

• AAPH for Reproducible Oxidative Stress Assays

  2026-08-13

  AAPH provides a water-soluble, sustained source of peroxyl radicals for erythrocyte hemolysis, lipid peroxidation, antioxidant screening, and protein-oxidation workflows. This guide translates evidence from hazelnut protein research into practical dose–time designs, controls, and troubleshooting strategies for reproducible in vitro oxidative damage models.

• TUDCA: From ER Stress to Translational Strategy

  2026-08-12

  Tauroursodeoxycholic Acid (TUDCA) offers translational researchers a mechanistically grounded way to connect ER proteostasis, mitochondrial stability, inflammation, and apoptosis. This thought-leadership perspective examines how TUDCA can strengthen experimental design across neurodegenerative disease models, metabolic disorder studies, and regenerative medicine research while defining the limits of pathway-based interpretation.

• Dual-Action Inhibition of p38α Dephosphorylation

  2026-08-12

  A 2024 bioRxiv study shows that selected kinase inhibitors can do more than block p38α catalysis: they can also accelerate WIP1-mediated dephosphorylation by exposing the activation-loop phospho-threonine. The structural and biochemical results introduce conformational control of kinase deactivation as a potential route to improved inhibitor potency and specificity.

• Praeruptorin A Workflows for Translational Research

  2026-08-11

  Praeruptorin A is a multi-pathway tool for linking ferroptosis, inflammation, barrier repair, cardiomyopathy research, and tumor-cell motility in one experimental strategy. This guide translates its reported DMT1, STAT, NF-κB, ERK1/2, and MMP1 activity into practical assay design, dose selection, and troubleshooting decisions.

• Psoralen-Induced Cholestasis via ERK1/2 Activation

  2026-08-11

  Chen and colleagues show that the estrogen-like natural products psoralen and isopsoralen trigger cholestatic liver injury in zebrafish larvae through ERK1/2 activation. By combining estrogenic assays, hepatobiliary phenotyping, gene-expression analysis, and pharmacological rescue, the study identifies ERK1/2 as a testable mechanistic node in phytoestrogen-associated cholestasis.

• S Tag Peptide: Fusion Tag Workflow Guide

  2026-08-10

  S Tag Peptide is a 15-amino-acid RNase A-derived tag used to support protein solubility improvement and antibody-based recombinant protein detection when genetically fused to a target. This guide covers construct design, solution handling, QC, and troubleshooting; it is not intended for ethanol-based solubilization or workflows requiring standalone ribonuclease activity.

• NVP-BGJ398 Phosphate: An FGFR Assay Playbook

  2026-08-09

  NVP-BGJ398 phosphate is a potent FGFR1–3 research inhibitor with value beyond a simple proliferation assay. This guide connects receptor pharmacology, genotype selection, phospho-signaling measurements, and the SLC26A2 skeletal-disease study into a practical experimental framework.

• NVP-BGJ398 phosphate: FGFR Workflow

  2026-08-08

  NVP-BGJ398 phosphate provides a practical way to connect FGFR1–3 blockade with measurable changes in ERK1/2 signaling, proliferation, apoptosis, and differentiation. This workflow covers cancer models, FGFR2-driven endometrial systems, FGF19 copy number gain, and the emerging skeletal-disease application while emphasizing formulation control and assay validation.

• Anlotinib Hydrochloride: Mechanism and Research Use

  2026-08-07

  Anlotinib hydrochloride is a multi-target tyrosine kinase inhibitor with activity against VEGFR2, PDGFRβ, and FGFR1. Its anti-angiogenic profile supports endothelial migration studies, capillary tube formation assays, ERK pathway experiments, and broader cancer research, while animal pharmacokinetics and a single case report should not be treated as human dosing evidence.

• O-GlcNAcylation Drives Wnt-Induced Glycolytic Bone Formation

  2026-08-07

  This study reveals that O-GlcNAcylation is indispensable for Wnt3a-stimulated bone formation, acting via metabolic rewiring of aerobic glycolysis. By dissecting the Ca2+-PKA-GFAT1 axis and its impact on protein modification, the findings clarify essential signaling mechanisms underlying osteoblast differentiation and bone anabolism.

• S1P/S1PR3 Drives Neuronal Apoptosis via TNF-α/Caspase-3 Afte

  2026-08-06

  The reference study elucidates how sphingosine-1-phosphate (S1P) signaling through S1PR3 exacerbates neuronal apoptosis after acute intracerebral hemorrhage (ICH) by activating the TNF-α/caspase-3 pathway. This mechanistic insight highlights S1PR3 as a promising therapeutic target for neuroprotection in stroke models.

• Puromycin Aminonucleoside in Podocyte Injury Models: Protoco

  2026-08-06

  Puromycin aminonucleoside is a gold-standard nephrotoxic agent for modeling podocyte injury and focal segmental glomerulosclerosis (FSGS) in experimental systems. This article provides actionable workflows, troubleshooting strategies, and cross-validated data to help researchers harness its full utility in nephrotic syndrome research.

16000 records 1/1067 page Next 12345 下5页 Last page